+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The levonorgestrel intrauterine system: cohort study to assess satisfaction in a postpartum population in Kenya



The levonorgestrel intrauterine system: cohort study to assess satisfaction in a postpartum population in Kenya



Contraception 91(4): 295-300



The levonorgestrel intrauterine system (LNG IUS) may become the next long-acting contraceptive to be introduced in public sector programs of resource-poor countries. Whereas service provision for subdermal implants and intrauterine devices is growing, little is known about how the LNG IUS might fit in. We conducted a cohort study of 313 women in Kenya who were 6-12 weeks postpartum when they started using these methods: subdermal implant (205), LNG IUS (93), and copper intrauterine device (15). Participants returned for visits at 6 and 12 months to share information on bleeding patterns, side effects, satisfaction, and continued use of the products. We used Kaplan-Meier techniques to estimate method continuation rates and chi-square tests of association to identify differences in experiences with the methods. The 12-month continuation rate for the LNG IUS was 89.1 (95% confidence interval [CI] = 86.9-94.9) and statistically equivalent to that of the subdermal implant (91.8: 95% CI = 80.6-94.0). Nearly 87% of LNG IUS users were very satisfied with the method at 6 months compared to 75% of implant users; this gap closed somewhat at 12 months as satisfaction levels of implant users rose. At 12 months 78% of LNG IUS users felt that their bleeding pattern was highly acceptable compared with about 66% of implant users. This study found that the LNG IUS compared favorably to the subdermal implant in terms of satisfaction levels and continued use. The LNG IUS will provide another long-acting option for postpartum women. The LNG IUS may soon be purchased by international donor agencies for use in public sector programs in sub-Saharan Africa and other resource-poor countries. The results of this study suggest that the product will be successful in future introduction activities.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059083626

Download citation: RISBibTeXText

PMID: 25601351

DOI: 10.1016/j.contraception.2015.01.009


Related references

A randomised clinical trial to assess satisfaction with the levonorgestrel- releasing intrauterine system inserted at caesarean section compared to postpartum placement. Australian and New Zealand Journal of Obstetrics and Gynaecology 55(3): 279-283, 2016

Uptake of the levonorgestrel intrauterine system among recent postpartum women in Kenya: factors associated with decision-making. Contraception 88(1): 97-102, 2014

Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort study. Contraception 2019, 2019

Feasibility of postpartum placement of the levonorgestrel intrauterine system more than 6 h after vaginal birth. Contraception 85(4): 359-362, 2012

Advance information improves user satisfaction with the levonorgestrel intrauterine system. Obstetrics & Gynecology 99(4): 608-613, 2002

Advance Information Improves User Satisfaction With the Levonorgestrel Intrauterine System. Obstetrics & Gynecology 99(4): 608-613, 2002

Comparison of combined transcervical resection of the endometrium and levonorgestrel-containing intrauterine system treatment versus levonorgestrel-containing intrauterine system treatment alone in women with adenomyosis: a prospective clinical trial. Journal of Reproductive Medicine 58(7-8): 285-290, 2013

Bleeding pattern difference between levonorgestrel intrauterine system and copper intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women. Current Medical Research and Opinion 34(5): 873-880, 2018

Relationship between user satisfaction with the levonorgestrel-releasing intrauterine system and bleeding patterns. Journal of Obstetrics and Gynaecology Research 43(11): 1732-1737, 2017

Predictors of bleeding and user satisfaction during consecutive use of the levonorgestrel-releasing intrauterine system. Human Reproduction 25(6): 1423-1427, 2010

User satisfaction with a levonorgestrel-releasing intrauterine system (LNG-IUS): data from an international survey. European Journal of Contraception and Reproductive Health Care 14(6): 391-398, 2010

Experiences with the levonorgestrel-releasing intrauterine system in Kenya: qualitative interviews with users and their partners. European Journal of Contraception and Reproductive Health Care 23(4): 303-308, 2018

Postpartum insertion of levonorgestrel--intrauterine system at three time periods: a prospective randomized pilot study. Contraception 84(3): 244-248, 2012

Levonorgestrel-releasing intrauterine system for treating menstrual disorders: a patient satisfaction questionnaire. Australian and New Zealand Journal of Obstetrics and Gynaecology 44(3): 247-251, 2004

Patient satisfaction for levonorgestrel intrauterine system and norethisterone for treatment of dysfunctional uterine bleeding. Journal of Ayub Medical College, Abbottabad 24(1): 23-26, 2013